Subscribe
Sign in
Home
Events Roundup
Healthtech Pigeon
About us at SomX
Archive
About
Latest
Top
Discussions
#68 – Heatproof bugs, high-yield bonds & herpes vectors
The coffee break biotech roundup, by SomX.
Oct 18
1
#67 – Assassinations, acquisitions, and autoimmune ambition
The coffee break biotech roundup, by SomX.
Oct 11
#66 – Irish science, cardiac silence, and fibrotic defiance
The coffee break biotech roundup, by SomX.
Oct 4
September 2025
#65 – Feathered dreams and gene therapy schemes
The coffee break biotech roundup, by SomX.
Sep 27
1
#64 – Frozen funding, vanishing labs, and stem cells for strokes
The coffee break biotech roundup, by SomX.
Sep 20
1
#63 – Mind the mitochondria: biotech takes aim at Parkinson’s & ALS
The coffee break biotech roundup, by SomX.
Sep 13
3
#62 - Mind the mozzies: biotech bites back
The coffee break biotech roundup, by SomX.
Sep 6
1
August 2025
#61 - This little piggy had a transplant
The coffee break biotech roundup, by SomX.
Aug 30
1
#60 - New approvals, new models, new money
The coffee break biotech roundup, by SomX.
Aug 25
#59 - Cell-ebrate good times, come on!
The coffee break biotech roundup, by SomX.
Aug 18
#58 - Choc, stock and two smoking trials
The coffee break biotech roundup, by SomX.
Aug 9
1
#57 - AI sharpens up, Merck makes cuts & FDA yields
The coffee break biotech roundup, by SomX.
Aug 2
3
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
